Hofseth Biocare ASA (HBC) — Working Capital to Net Assets Ratio
Hofseth Biocare ASA (HBC) has a Working Capital to Net Assets ratio of 146.8% as of September 2025. Working capital of Nkr-40.89 Million (current assets of Nkr176.36 Million minus current liabilities of Nkr217.25 Million) is measured against net assets of Nkr-27.85 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see balance sheet size of Hofseth Biocare ASA.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Hofseth Biocare ASA Working Capital to Net Assets (2010–2024)
This chart shows how Hofseth Biocare ASA's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2010 to 2024. As of September 2025, the ratio stands at 146.8%, reflecting working capital of Nkr-40.89 Million against net assets of Nkr-27.85 Million NOK. Explore Hofseth Biocare ASA (HBC) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Annual Working Capital to Net Assets for Hofseth Biocare ASA (2010–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Hofseth Biocare ASA from 2010 to 2024, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Explore investment intensity of Hofseth Biocare ASA to see how much of total assets are deployed in long-term investments.
| Year | WC/NA Ratio | Working Capital (NOK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -91.9% | Nkr-56.36 Million | Nkr61.30 Million | Nkr112.06 Million | Nkr168.42 Million | ▲ +201.9 pp |
| 2023 | -293.8% | Nkr-120.87 Million | Nkr41.14 Million | Nkr131.00 Million | Nkr251.88 Million | ▼ -296.2 pp |
| 2022 | 2.4% | Nkr3.52 Million | Nkr148.03 Million | Nkr175.75 Million | Nkr172.23 Million | ▼ -11.4 pp |
| 2021 | 13.8% | Nkr19.38 Million | Nkr140.38 Million | Nkr170.31 Million | Nkr150.93 Million | ▼ -48.9 pp |
| 2020 | 62.7% | Nkr165.29 Million | Nkr263.76 Million | Nkr271.47 Million | Nkr106.18 Million | ▲ +6.5 pp |
| 2019 | 56.1% | Nkr66.10 Million | Nkr117.75 Million | Nkr137.85 Million | Nkr71.75 Million | ▲ +22.7 pp |
| 2018 | 33.5% | Nkr28.80 Million | Nkr86.04 Million | Nkr100.32 Million | Nkr71.51 Million | ▲ +54.8 pp |
| 2017 | -21.4% | Nkr-7.92 Million | Nkr37.08 Million | Nkr94.89 Million | Nkr102.81 Million | ▲ +21.0 pp |
| 2016 | -42.3% | Nkr-22.67 Million | Nkr53.56 Million | Nkr37.48 Million | Nkr60.15 Million | ▼ -82.7 pp |
| 2015 | 40.4% | Nkr13.14 Million | Nkr32.55 Million | Nkr87.87 Million | Nkr74.73 Million | ▲ +23.0 pp |
| 2014 | 17.3% | Nkr13.69 Million | Nkr78.95 Million | Nkr106.49 Million | Nkr92.80 Million | ▲ +43.9 pp |
| 2013 | -26.5% | Nkr-16.46 Million | Nkr62.00 Million | Nkr90.83 Million | Nkr107.29 Million | ▲ +44.7 pp |
| 2012 | -71.3% | Nkr-34.01 Million | Nkr47.72 Million | Nkr43.58 Million | Nkr77.59 Million | ▼ -91.9 pp |
| 2011 | 20.6% | Nkr24.82 Million | Nkr120.53 Million | Nkr40.24 Million | Nkr15.43 Million | ▲ +20.1 pp |
| 2010 | 0.5% | Nkr396.00K | Nkr75.97 Million | Nkr14.55 Million | Nkr14.16 Million | — |